Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total Shareholders Equity [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Oct. 31, 2020 $ 242 $ 200,355 $ (191,836) $ 8,761 $ (497) $ 8,264
Beginning balance, shares at Oct. 31, 2020 24,248,695          
Stock option compensation to employees and directors 4,804 4,804 4,804
Stock options and warrants issued to consultants 421 421 421
Common stock issued upon exercise of stock options $ 1 292 293 293
Common stock issued upon exercise of stock options, shares 107,451          
Net loss (8,941) (8,941) (116) (9,057)
Expired restricted stock award to employee $ (15) 15  
Expired restricted stock award to employee, shares (1,500,000)          
Common stock issued pursuant to employee stock purchase plan 3 3 3
Common stock issued pursuant to employee stock purchase plan, shares 1,634          
Common stock issued in a public offering, net of offering expenses of $2,208 $ 43 20,249 20,292 20,292
Common stock issued in a public offering, net of offering expenses, shares 4,285,715          
Common stock issued in at-the-market offering, net of offering expenses of $341 $ 29 10,805 10,834 10,834
Common stock issued in at-the-market offering, net of offering expenses, shares 2,806,410          
Balance, July, 2021 at Jul. 31, 2021 $ 300 236,944 (200,777) 36,467 (613) 35,854
Ending balance, shares at Jul. 31, 2021 29,949,905          
Beginning balance, value at Apr. 30, 2021 $ 315 233,742 (196,443) 37,614 (559) 37,055
Beginning balance, shares at Apr. 30, 2021 31,449,905          
Stock option compensation to employees and directors 3,048 3,048 3,048
Common stock issued to consultants 139 139 139
Net loss (4,334) (4,334) (54) (4,388)
Expired restricted stock award to employee $ (15) 15
Expired restricted stock award to employee, shares (1,500,000)          
Balance, July, 2021 at Jul. 31, 2021 $ 300 236,944 (200,777) 36,467 (613) 35,854
Ending balance, shares at Jul. 31, 2021 29,949,905          
Beginning balance, value at Oct. 31, 2021 $ 301 239,927 (204,790) 35,438 (671) 34,767
Beginning balance, shares at Oct. 31, 2021 30,050,894          
Common stock issued upon exercise of stock options and warrants, shares at Oct. 31, 2021 577,473          
Stock option compensation to employees and directors 4,928 4,928 4,928
Stock options and warrants issued to consultants 546 546 $ 546
Common stock issued upon exercise of stock options, shares           956,388
Common stock issued to consultants 72 72 $ 72
Common stock issued to consultants, shares 22,662          
Net loss (10,119) (10,119) (123) (10,242)
Common stock issued upon exercise of stock options and warrants 6 824 830 830
Common stock issued pursuant to employee stock purchase plan 6 6 6
Common stock issued pursuant to employee stock purchase plan, shares 2,389          
Balance, July, 2021 at Jul. 31, 2022 $ 307 246,303 (214,909) 31,701 (794) 30,907
Ending balance, shares at Jul. 31, 2022 30,653,418          
Beginning balance, value at Apr. 30, 2022 $ 302 244,032 (212,163) 32,171 (765) 31,406
Beginning balance, shares at Apr. 30, 2022 30,154,708          
Stock option compensation to employees and directors 1,329 1,329 1,329
Stock options and warrants issued to consultants 109 109 109
Common stock issued upon exercise of stock options $ 5 825 830 830
Common stock issued upon exercise of stock options, shares 496,048          
Common stock issued to consultants 8 8 8
Common stock issued to consultants, shares 2,662          
Net loss (2,746) (2,746) (29) (2,775)
Balance, July, 2021 at Jul. 31, 2022 $ 307 $ 246,303 $ (214,909) $ 31,701 $ (794) $ 30,907
Ending balance, shares at Jul. 31, 2022 30,653,418